215 related articles for article (PubMed ID: 27279145)
21. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
[TBL] [Abstract][Full Text] [Related]
22. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
Sun MY; Wang L; Shen ZY
Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
[TBL] [Abstract][Full Text] [Related]
23. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
[TBL] [Abstract][Full Text] [Related]
24. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
Qu Y; He Y; Ruan H; Qin L; Han Z
Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
[TBL] [Abstract][Full Text] [Related]
25. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.
Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M
J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907
[TBL] [Abstract][Full Text] [Related]
26. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
27. RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway.
Wang F; Yamauchi M; Muramatsu M; Osawa T; Tsuchida R; Shibuya M
J Biol Chem; 2011 Mar; 286(11):9097-106. PubMed ID: 21212275
[TBL] [Abstract][Full Text] [Related]
28. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
30. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
31. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
[TBL] [Abstract][Full Text] [Related]
32. Pathologic significance of AKT, mTOR, and GSK3β proteins in oral squamous cell carcinoma-affected patients.
Matsuo FS; Andrade MF; Loyola AM; da Silva SJ; Silva MJB; Cardoso SV; de Faria PR
Virchows Arch; 2018 Jun; 472(6):983-997. PubMed ID: 29713826
[TBL] [Abstract][Full Text] [Related]
33. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
He W; Lai R; Lin Q; Huang Y; Wang L
J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
[TBL] [Abstract][Full Text] [Related]
34. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
35. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
[TBL] [Abstract][Full Text] [Related]
36. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
Wang M; Feng Z; Li X; Sun S; Lu L
Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
[TBL] [Abstract][Full Text] [Related]
37. Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.
Wei M; Wu Y; Liu H; Xie C
Drug Des Devel Ther; 2020; 14():395-405. PubMed ID: 32099325
[TBL] [Abstract][Full Text] [Related]
38. [Study on the correlation between combined detection of RACK1 and M2/M1 in oral squamous cell carcinoma and prognosis of the patients].
Zhu J; Xu T; Song DH; Wu SB
Shanghai Kou Qiang Yi Xue; 2022 Oct; 31(5):517-522. PubMed ID: 36758601
[TBL] [Abstract][Full Text] [Related]
39. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
40. The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.
Sun Y; Yang X; Guan S; Ma T; Jiang Z; Gao M; Xu Y; Cong B
Arch Oral Biol; 2023 Dec; 156():105810. PubMed ID: 37852106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]